Mann J, Thomas K M
Br J Psychiatry. 1979 Apr;134:366-71.
A study was made of platelet monoamine oxidase (MAO) activity in non-medicated, newly-admitted schizophrenics and institutionalized chronic schizophrenics both on and off medication. These patients were compared to two control groups: normal subjects and brain-damaged institutionalized patients. No relationship was found between platelet MAO activity and the severity or duration of illness, duration of psychotropic medication, presence of auditory hallucinations or institutionalization. Mean platelet MAO activity did not differ significantly between the schizophrenic subgroups and control groups. Thirty-one patients studied before and after treatment with phenothiazines showed no significant change in platelet MAO activity. The findings did not indicate a relationship between schizophrenia, its treatment or outcome and platelet MAO activity.
一项针对未用药的新入院精神分裂症患者以及住院治疗的慢性精神分裂症患者(包括正在用药和未用药的)的血小板单胺氧化酶(MAO)活性进行了研究。这些患者与两个对照组进行了比较:正常受试者和住院治疗的脑损伤患者。未发现血小板MAO活性与疾病的严重程度或持续时间、精神药物治疗的持续时间、幻听的存在或住院时间之间存在关联。精神分裂症亚组与对照组之间的平均血小板MAO活性无显著差异。31例接受吩噻嗪治疗前后进行研究的患者,其血小板MAO活性无显著变化。研究结果并未表明精神分裂症及其治疗或预后与血小板MAO活性之间存在关联。